White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment

AIDS

Volumn 30, Issue 2, 2016, Pages 311-322

  Su, Tanja ^a   Caan, Matthan W A ^a   Wit, Ferdinand W N M ^a,b   Schouten, Judith ^a,b   Geurtsen, Gert J ^a   Cole, James H ^c   Sharp, David J ^c   Vos, Frans M ^d   Prins, Maria ^b,e   Portegies, Peter ^a,f   Reiss, Peter ^a,b,g   Majoie, Charles B ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^f Onze Lieve Vrouwe Gasthuis (OLVG Hospital)   (Netherlands)

^g STICHTING HIV MONITORING   (Netherlands)

Author keywords

Aging; Antiretroviral therapy; Cerebral white matter; Diffusion tensor imaging (DTI); HIV 1 infection; HIV associated neurocognitive disorders (HAND); Neuropsychological assessment

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIHYPERTENSIVE AGENT; CD14 ANTIGEN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BRAIN SIZE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OBESITY; PRIORITY JOURNAL; SMOKING; SUBSTANCE USE; TOBACCO USE; TREATMENT DURATION; VIRUS REPLICATION; WAIST HIP RATIO; WHITE MATTER; WHITE MATTER LESION; AIDS DEMENTIA COMPLEX; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; LEUKOENCEPHALOPATHIES; MIDDLE AGED; PATHOLOGY; VIROLOGY;

AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; DIFFUSION TENSOR IMAGING; HIV INFECTIONS; HIV-1; HUMANS; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; WHITE MATTER;

EID: 84952943643     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000945     Document Type: Article

References (62)

1. Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 2013; 177:116-125.
2. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011; 25:561-575.
3. Anthony IC, Bell JE. The neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20:15-24.
4. Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS. Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res 2014; 2014:569819.
5. Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis 2007; 196:1779-1783.
6. Manji H, Jäger HR, Winston A. HIV, dementia and antiretroviral drugs: 30 years of an epidemic. J Neurol Neurosurg Psychiatry 2013; 84:1126-1137.
7. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-1139.
8. Schouten J, Wit FW, Stolte IG, Kootstra N, van der Valk M, Geerlings SG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis 2014:1-29.
9. Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol 2014; 11:728-741.
10. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
11. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. J Magn Reson 2011; 213:560-570.
12. Sun S-W, Liang H-F, Trinkaus K, Cross AH, Armstrong RC, Song S-K. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 2006; 55:302-308.
13. Song S-K, Sun S-W, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002; 17:1429-1436.
14. Filippi CG, Ulug a M, Ryan E, Ferrando SJ, van Gorp W. Diffusion tensor imaging of patients with HIV and normalappearing white matter on MR images of the brain. AJNR Am J Neuroradiol 2001; 22:277-283.
15. Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 2001; 106:15-24.
16. Pfefferbaum A, Rosenbloom MJ, Adalsteinsson E, Sullivan EV. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain 2007; 130:48-64.
17. Hoare J, Fouche JP, Spottiswoode B, Joska JA, Schoeman R, Stein DJ, Carey PD. White matter correlates of apathy in HIV-positive subjects: a diffusion tensor imaging study. J Neuropsychiatry Clin Neurosci 2010; 22:313-320.
18. Hoare J, Jacqueline H, Westgarth-Taylor J, Jenny W, Fouche J-P, Jean-Paul F, et al. A diffusion tensor imaging and neuropsychological study of prospective memory impairment in South African HIVpositive individuals.Metab Brain Dis 2012; 27:289-297.
19. Müller-Oehring EM, Schulte T, Rosenbloom MJ, Pfefferbaum A, Sullivan EV. Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia 2010; 48:1133-1143.
20. Leite SCB, Correa DG, Doring TM, Kubo TT, Netto TM, Ferracini R, et al. Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients. J Magn Reson Imaging 2013; 38:1488-1493.
21. Ragin AB, Storey P, Cohen BA, Edelman RR, Epstein LG. Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 2004; 63:2293-2297.
22. Thurnher MM, Castillo M, Stadler A, Rieger A, Schmid B, Sundgren PC. Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am J Neuroradiol 2005; 26:2275-2281.
23. Wu Y, Storey P, Cohen BA, Epstein LG, Edelman RR, Ragin AB. Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 2006; 27:656-660.
24. Chen Y, An H, Zhu H, Stone T, Smith JK, Hall C, et al. White matter abnormalities revealed by diffusion tensor imaging in nondemented and demented HIVR patients. Neuroimage 2009; 47:1154-1162.
25. Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, Sullivan EV. Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS 2009; 23:1977-1985.
26. Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, Martin E, et al. HIV-associated alterations in normal-appearing white matter. J Acquir Immune Defic Syndr 2007; 46:564-573.
27. Chang L, Wong V, Nakama H, Watters M, Ramones D, Miller EN, et al. Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol 2008; 3:265-274.
28. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, et al. White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals. J Neurovirol 2009; 15:187-195.
29. Du H, Wu Y, Ochs R, Edelman RR, Epstein LG, McArthur J, et al. A comparative evaluation of quantitative neuroimaging measurements of brain status in HIV infection. Psychiatry Res 2012; 203:95-99.
30. Nakamoto BK, Jahanshad N, McMurtray A, Kallianpur KJ, Chow DC, Valcour VG, et al. Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individuals. J Neurovirol 2012; 18:303-312.
31. Stubbe-Drger B, Deppe M, Mohammadi S, Keller SS, Kugel H, Gregor N, et al. Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study. BMC Neurol 2012; 12:23.
32. Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, et al. Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav 2010; 4:68-79.
33. Zhu T, Zhong J, Hu R, Tivarus M, Ekholm S, Harezlak J, et al. Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study. J Neurovirol 2013; 19:10-23.
34. Nir TM, Jahanshad N, Busovaca E, Wendelken L, Nicolas K, Thompson PM, et al. Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp 2014; 35:975-992.
35. Wright PW, Heaps JM, Shimony JS, Thomas JB, Ances BM. The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS 2012; 26:1501-1508.
36. Wright PW, Vaida FF, Fernández RJ, Rutlin J, Price RW, Lee E, et al. Cerebral white matter integrity during primary HIV infection. AIDS 2015; 29:433-442.
37. Ragin AB, Wu Y, Storey P, Cohen BA, Edelman RR, Epstein LG. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 2005; 11:292-298.
38. Schulte T, Müller-Oehring EM, Javitz H, Pfefferbaum A, Sullivan EV. Callosal compromise differentially affects conflict processing and attentional allocation in alcoholism, HIV, and their comorbidity. Brain Imaging Behav 2008; 2:27-38.
39. Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Kumar A, Soni S, et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 2012; 48:230-241.
40. Gongvatana A, Cohen RA, Correia S, Devlin KN, Miles J, Kang H, et al. Clinical contributors to cerebral white matter integrity in HIV-infected individuals. J Neurovirol 2011; 17:477-486.
41. Huizenga HM, Smeding H, Grasman RP, Schmand B. Multivariate normative comparisons. Neuropsychologia 2007; 45:2534-2542.
42. Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, et al. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS 2015doi:101097/QAD0000000000000573.
43. Shahand S, Benabdelkader A, Jaghoori MM, al Mourabit M, Huguet J, Caan MWA, et al. A data-centric neuroscience gateway: design, implementation, and experiences. Concurr Comput Pract Exp 2015; 27:489-506.
44. Leemans A, Jones DK. The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009; 61:1336-1349.
45. Caan MW, Khedoe G, Poot D, den Dekker A, Olabarriaga S, Grimbergen K, et al. Adaptive noise filtering for accurate and precise diffusion estimation in fiber crossings. Med Image Comput Comput Assist Interv 2010; 13:167-174.
46. Andersson JLR, Jenkinson M, Smith S. Nonlinear registration aka spatial normalisation. FMRIB Technial Report, TR07JA2; 2007.
47. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multisubject diffusion data. Neuroimage 2006; 31:1487-1505.
48. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (Suppl 1):S208-S219.
49. Ashburner J, Friston KJ. Unified segmentation. NeuroImage 2005; 26:839-851.
50. Steenwijk MD, Pouwels PJW, Daams M, van Dalen JW, Caan MW, Richard E, et al. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). NeuroImage Clin 2013; 3:462-469.
51. Breiman L. Random forests. Mach Learn 2001; 45:1-35.
52. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
53. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Rockville, Maryland: Department of Health and Human Services; 2007.
54. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64:529-536.
55. Lange RT, Shewchuk JR, Heran MKS, Rauscher A, Jarrett M, Brubacher JR, et al. To exclude or not to exclude: further examination of the influence of white matter hyperintensities in diffusion tensor imaging research. J Neurotrauma 2014; 31:198-205.
56. Schmand B, Lindeboom J, van Harskamp F. Dutch adult reading test. Lisse: Swets en Zeitlinger; 1992.
57. Letendre SL, Ellis RJ, Ances BM, McCutchan JA. Neurologic complications of HIV disease and their treatment. Top HIV Med 2010; 18:45-55.
58. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl 1):S81-90.
59. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005; 7:102-109.
60. Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, et al. Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010; 28:2068-2075.
61. Baulmann J, Schillings U, Rickert S, Uen S, Düsing R, Illyes M, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens 2008; 26:523-528.
62. WHO. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, Switzerland: WHO; 2008.